Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-158.03K) by net assets ($196.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Oaktree Acquisition Corp. III Life Scien (OACC) balance sheet quality index to measure how much of total assets are equity-financed.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share - Cash Flow Conversion Efficiency Trend (2024–2025)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OACC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AME Elite Consortium Bhd
KLSE:5293
|
-0.137x |
|
Strike Energy Limited
F:RJN
|
-0.013x |
|
Melon SA
SN:MELON
|
0.064x |
|
Iberpapel Gestion SA
MC:IBG
|
0.040x |
|
ThinTech Materials Technology Co Ltd
TWO:3663
|
-0.061x |
|
Favite Inc
TW:3535
|
0.039x |
|
XINTE ENERGY CO. CL.H YC1
F:9M7
|
N/A |
|
SBC Exports Limited
NSE:SBC
|
0.009x |
Annual Cash Flow Conversion Efficiency for Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (2024–2025)
The table below shows the annual cash flow conversion efficiency of Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share from 2024 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Oaktree Acquisition Corp. III Life Scien worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $194.79 Million | $-422.08K | -0.002x | -353.00% |
| 2024-12-31 | $187.50 Million | $-89.69K | 0.000x | -- |
About Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more